Ronald S Oosting Selected Research

Ronald S Oosting Research Topics

4	Memory Disorders (Memory Loss) 12/2012 - 01/2012
3	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 06/2014 - 08/2010
3	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2014 - 10/2012
2	Infections 08/2017 - 08/2009
2	Alzheimer Disease (Alzheimer's Disease) 04/2014 - 04/2012
2	Cognitive Dysfunction 10/2012 - 08/2011
2	Anxiety Disorders (Anxiety Disorder) 03/2011 - 02/2003
1	Major Depressive Disorder (Major Depressive Disorders) 01/2016
1	Shock 09/2012
1	Lordosis 04/2011
1	Parkinson Disease (Parkinson's Disease) 08/2009
1	Fever (Fevers) 08/2009
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 03/2006
1	Tachycardia (Tachyarrhythmias) 09/2002

3	Pharmaceutical PreparationsIBA 08/2017 - 08/2009
3	5-HT1A Serotonin ReceptorIBA 01/2016 - 09/2002
2	Memantine (Namenda)FDA Link 04/2014 - 04/2012
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2014 - 04/2012
2	Corticotropin-Releasing HormoneIBA 09/2012 - 02/2003
2	Antidepressive Agents (Antidepressants)IBA 01/2012 - 08/2010
2	Diazepam (Valium)FDA LinkGeneric 08/2009 - 09/2002
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2016
1	Vilazodone HydrochlorideIBA 01/2016
1	Serotonin (5 Hydroxytryptamine)IBA 06/2014
1	Glutamic Acid (Glutamate)FDA Link 04/2014
1	AntioxidantsIBA 04/2014
1	Minocycline (Cyclops)FDA LinkGeneric 12/2012
1	Celecoxib (Celebrex)FDA Link 10/2012
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2012
1	Glutamate Receptors (Glutamate Receptor)IBA 09/2012
1	Neuropeptide YIBA 09/2012
1	neuropeptide Y-Y1 receptorIBA 09/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2011
1	Paroxetine (Paxil)FDA LinkGeneric 04/2011
1	Dopamine (Intropin)FDA LinkGeneric 08/2009
1	Pramipexole (Mirapex)FDA LinkGeneric 08/2009
1	ProstaglandinsIBA 08/2009
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2009
1	GABA-A Receptor AgonistsIBA 08/2009
1	Methylphenidate (Ritalin)FDA LinkGeneric 03/2006
1	flesinoxanIBA 09/2002

1	Induced Hyperthermia (Thermotherapy) 08/2009